Crew Capital Management Ltd. bought a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 1,982 shares of the semiconductor company’s stock, valued at approximately $1,021,000. Synopsys accounts for approximately 1.0% of Crew Capital Management Ltd.’s investment portfolio, making the stock its 21st largest position.
A number of other institutional investors also recently bought and sold shares of the stock. FMR LLC raised its position in Synopsys by 8.9% during the 3rd quarter. FMR LLC now owns 4,032,059 shares of the semiconductor company’s stock worth $1,850,594,000 after buying an additional 330,206 shares during the last quarter. Ameriprise Financial Inc. raised its position in Synopsys by 20.3% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,041,275 shares of the semiconductor company’s stock worth $925,744,000 after buying an additional 344,430 shares during the last quarter. Northern Trust Corp raised its position in Synopsys by 4.9% during the 3rd quarter. Northern Trust Corp now owns 1,687,602 shares of the semiconductor company’s stock worth $774,559,000 after buying an additional 78,848 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in Synopsys by 4.3% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 885,083 shares of the semiconductor company’s stock worth $406,227,000 after buying an additional 36,470 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Synopsys by 0.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 826,010 shares of the semiconductor company’s stock worth $379,114,000 after buying an additional 7,294 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Price Performance
NASDAQ SNPS traded up $1.10 on Monday, hitting $544.76. The company had a trading volume of 647,499 shares, compared to its average volume of 1,230,210. The company has a market capitalization of $83.08 billion, a PE ratio of 59.84, a PEG ratio of 3.18 and a beta of 1.06. The company’s fifty day moving average price is $563.73 and its 200-day moving average price is $536.58. Synopsys, Inc. has a 12-month low of $365.46 and a 12-month high of $629.38.
Insider Buying and Selling
In other news, insider John F. Runkel, Jr. sold 1,219 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $583.95, for a total value of $711,835.05. Following the completion of the sale, the insider now directly owns 26,780 shares in the company, valued at $15,638,181. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, insider John F. Runkel, Jr. sold 1,219 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $583.95, for a total value of $711,835.05. Following the completion of the sale, the insider now directly owns 26,780 shares in the company, valued at $15,638,181. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Roy Vallee sold 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $572.66, for a total transaction of $5,726,600.00. Following the completion of the sale, the director now owns 20,000 shares of the company’s stock, valued at $11,453,200. The disclosure for this sale can be found here. In the last quarter, insiders sold 26,832 shares of company stock valued at $15,464,992. 0.66% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on SNPS. Needham & Company LLC reissued a “buy” rating and set a $660.00 price target on shares of Synopsys in a research report on Friday, March 22nd. Robert W. Baird lifted their target price on shares of Synopsys from $624.00 to $640.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. StockNews.com raised shares of Synopsys from a “hold” rating to a “buy” rating in a report on Monday, March 18th. Rosenblatt Securities reaffirmed a “buy” rating and set a $615.00 target price on shares of Synopsys in a report on Thursday, March 21st. Finally, Piper Sandler assumed coverage on shares of Synopsys in a report on Thursday, April 4th. They set an “overweight” rating and a $665.00 target price for the company. Eleven research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $601.00.
View Our Latest Report on Synopsys
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- What is Insider Trading? What You Can Learn from Insider Trading
- The 3 Hottest Insiders Buys This Month
- What Are Dividends? Buy the Best Dividend Stocks
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- P/E Ratio Calculation: How to Assess Stocks
- Microsoft Analysis: Trends, Predictions & Investment Insight
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.